Arcus Ventures

About The Fund

Arcus Ventures, established in 2007 and headquartered in New York, New York, is a venture capital firm committed to supporting innovation in the healthcare and life science sectors. Specifically, their focus is on companies operating within biotechnology, medical devices, oncology, bio-pharmaceuticals, drug delivery sectors, and health technology. With a clear oncology orientation, they seek out enterprises working on innovative biopharmaceuticals and novel drug delivery platforms. They also invest in device companies poised for pre-marketing approval and service companies already generating positive revenue. Their investment strategy involves providing substantial financial backing, with both minimum and maximum investment amounts sitting at approximately $30,290,000. This significant funding level illustrates their dedication to fueling substantial growth and development in their portfolio companies, aiming to deliver transformative healthcare solutions. The Arcus Ventures team comprises industry professionals with extensive expertise in clinical and academic medicine, drug development, hospital management, healthcare industry consulting, and private equity. This wealth of experience enables them to not only provide capital but also strategic support to the companies they invest in, helping to guide them through the intricacies of the competitive healthcare market. Their website highlights their advisory team, portfolio, and investment criteria, reinforcing their commitment to fostering advancements in oncology-focused companies. They regularly update their news section, showcasing their ongoing engagement and contributions to the healthcare investment landscape.